文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

One-pot ligation of multiple mRNA fragments on dsDNA splint advancing regional modification and translation.

作者信息

Xu Yunfan, Qi Shuopeng, Zhang Gongrui, Liu Dan, Xu Dejin, Qin Tong, Cheng Qin, Kang Han, Hu Bei, Huang Zhen

机构信息

Key Laboratory of Bio-resource and Eco-environment of Ministry of Education, The College of Life Sciences, Sichuan University, 24 South Section 1, 1st Ring Road, Chengdu, Sichuan 610064, P.R. China.

SeNA Research Institute, School of Life Sciences, Hubei University, 368 Youyi Avenue, Wuhan, Hubei 430062, P.R. China.

出版信息

Nucleic Acids Res. 2025 Jan 7;53(1). doi: 10.1093/nar/gkae1280.


DOI:10.1093/nar/gkae1280
PMID:39778864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11707544/
Abstract

Region-specific RNA modifications are crucial for advancing RNA research and therapeutics, including messenger RNA (mRNA)-based vaccines and immunotherapy. However, the predominant method, synthesizing regionally modified mRNAs with short single-stranded DNA (ssDNA) splints, encounters challenges in ligating long mRNA fragments due to the formation of RNA self-folded complex structures. To address this issue, we developed an efficient strategy using an easily obtained long double-stranded DNA (dsDNA) as a ligation splint after in situ denaturing, while parts of this dsDNA are the templates for transcribing mRNA fragments. We observed that the denatured dsDNA formed a long hybrid duplex with these mRNA fragments, overcoming their structures. Further, our novel strategy remarkably facilitated the ligation of long mRNA fragments (especially structured ones), offering ligation efficiency up to 106-fold higher than the ssDNA method. Using this one-pot strategy, we conveniently synthesized the mRNAs with N1-methylpseudouridine (m1ψ) and 5-methylcytidine (m5C) modifications in specific regions. We have found that compared with the fully modified mRNAs, the 3'UTR m1ψ modifications alone increased the translation efficiency, and the combined modifications of the m1ψ-3'UTR and m5C-5'UTR/CDS exhibited higher translation efficiency and lower immunogenicity in general. Our study presents a broadly applicable strategy for producing regionally modified mRNAs, advancing the potential of mRNA therapeutics.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d035/11707544/57d09dcbae77/gkae1280fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d035/11707544/7416c6185a0d/gkae1280figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d035/11707544/8d0e0e92a71f/gkae1280fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d035/11707544/370e4b123bd9/gkae1280fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d035/11707544/e33216ee2f0c/gkae1280fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d035/11707544/2faa5a67a47e/gkae1280fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d035/11707544/57d09dcbae77/gkae1280fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d035/11707544/7416c6185a0d/gkae1280figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d035/11707544/8d0e0e92a71f/gkae1280fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d035/11707544/370e4b123bd9/gkae1280fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d035/11707544/e33216ee2f0c/gkae1280fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d035/11707544/2faa5a67a47e/gkae1280fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d035/11707544/57d09dcbae77/gkae1280fig5.jpg

相似文献

[1]
One-pot ligation of multiple mRNA fragments on dsDNA splint advancing regional modification and translation.

Nucleic Acids Res. 2025-1-7

[2]
N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice.

J Control Release. 2015-9-3

[3]
Translational control of apolipoprotein B mRNA: regulation via cis elements in the 5' and 3' untranslated regions.

Biochemistry. 2004-6-1

[4]
Quantitative profiling of human translation initiation reveals elements that potently regulate endogenous and therapeutically modified mRNAs.

Mol Cell. 2025-1-16

[5]
Control of glutamate receptor 2 (GluR2) translational initiation by its alternative 3' untranslated regions.

Mol Pharmacol. 2009-12

[6]
N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products.

Cell Rep. 2022-8-30

[7]
Optimizing mRNA translation efficiency through rational 5'UTR and 3'UTR combinatorial design.

Gene. 2025-3-20

[8]
N 1-Methylpseudouridine substitution enhances the performance of synthetic mRNA switches in cells.

Nucleic Acids Res. 2020-4-6

[9]
A sequence predicted to form a stem-loop is proposed to be required for formation of an RNA-protein complex involving the 3'UTR of beta-subunit F0F1-ATPase mRNA.

Biochim Biophys Acta. 2008

[10]
Untranslated Region Sequences and the Efficacy of mRNA Vaccines against Tuberculosis.

Int J Mol Sci. 2024-1-10

本文引用的文献

[1]
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia.

Nature. 2024-4

[2]
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.

Lancet. 2024-2-17

[3]
N-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting.

Nature. 2024-1

[4]
Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa.

NPJ Vaccines. 2023-5-25

[5]
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.

Nature. 2023-6

[6]
De novo design of luciferases using deep learning.

Nature. 2023-2

[7]
Synthesis of point-modified mRNA.

Nucleic Acids Res. 2022-11-11

[8]
Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.

Lancet Infect Dis. 2022-9

[9]
mRNA-based therapeutics: powerful and versatile tools to combat diseases.

Signal Transduct Target Ther. 2022-5-21

[10]
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.

N Engl J Med. 2022-5-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索